Venetoclax combined with azacitidine in the treatment of secondary myelodysplastic syndrome following multiple myeloma: a case report and literature review - Quiz - MDSpire

Venetoclax combined with azacitidine in the treatment of secondary myelodysplastic syndrome following multiple myeloma: a case report and literature review

  • By

  • Lijun Shi

  • Zhongrui Ma

  • Xia Yu

  • Tian Wang

  • Li Wei

  • Yaning Pan

  • Tantian Jiang

  • Xiujin Wu

  • July 14, 2026

Share

Original Source(s)

Venetoclax combined with azacitidine in the treatment of secondary myelodysplastic syndrome following multiple myeloma: a case report and literature review

  • by Lijun Shi, Zhongrui Ma, Xia Yu, Tian Wang, Li Wei, Yaning Pan, Tantian Jiang, Xiujin Wu

  • July 14, 2026

Related Content

Navigating the gut–metabolite–immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors

A hybrid ViT-L/32–MaxViT-L architecture with adaptive gated fusion for multiclass gastrointestinal disease detection and multi-method post-hoc explainability

A novel H2A-A127 variant is associated with human cancer and enhances tumor-related phenotypes in Drosophila melanogaster models